Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations,2018
August 1, 2020
Disclosure of material impact of COVID-19 Pandemic
August 1, 2020
Regulation 24A- Annual Secretarial Compliance report
August 1, 2020
Intimation under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements ) Regulations,2015
July 1, 2020
Board meeting Intimation-June 26,2020
June 26, 2020
Corporate Governance Report -30.06.2020
June 1, 2020
Implementation of the Approved Resolution plan and in
April 1, 2020
Certificate under Regulation 40(9) of SEBI(LODR), Regulations,2015 for the half year ended March 31,2020
April 1, 2020
Certificate under Regulation 7(3) for the half year ended March 31,2020
April 1, 2020
Reconciliation report for the quarter ended March 31,2020
April 1, 2020
Appointment of Company Secretary - Luxem
March 5, 2020
Appointment of Company Secretary - NSEBSE
March 5, 2020
CIRP updates - Luxem
March 3, 2020
CIRP updates - NSEBSE
March 3, 2020
Notice of Board Meeting December 2019
February 11, 2020
Reconciliation of Share Capital Audit 31.12.2019
February 1, 2020
Previous
1
...
Next
25 / 36